+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Survival and prognostic factors of surgically resected T4 non-small cell lung cancer



Survival and prognostic factors of surgically resected T4 non-small cell lung cancer



Annals of Thoracic Surgery 75(6): 1745



Category T4 nonsmall cell lung cancer (NSCLC) encompasses heterogenous subgroups. We retrospectively analyzed the survival of patients with surgically resected T4 NSCLC to evaluate the evidence for prognostic implications according to the subgroups of T4 category, nodal status, and resection completeness. Seventy-six patients with T4N0-2M0 NSCLC were divided into three subgroups within the T4 category: 24 patients with the tumor invading the mediastinal organs (mediastinal group), 16 with a malignant pleural effusion or dissemination (pleural group), and 36 with satellite tumor nodules within the ipsilateral primary tumor lobe (satellite group). Complete resection was possible in 47 patients (61.8%). The pathologic N statuses were N0 in 28, N1 in 13, and N2 in 35 patients. The overall survival of the 76 patients was 19.1% at 5 years. The overall 5-year survivals according to the three subgroups of the T4 category were as follows: mediastinal group, 18.2%; pleural group, 0%; and satellite group, 26.7% (mediastinal/satellite versus pleural, p = 0.037). Factors significantly influencing the overall 5-year survival were the pathologic N status (N2 versus N0-1, p = 0.022) and the completeness of resection (complete versus incomplete, p = 0.0001). A multivariate survival analysis demonstrated that the pathologic N status and the completeness of resection were significant independent predictors of a poorer prognosis even after adjusting for the subgroup of the T4 category. Resectable T4N0-1 NSCLC that is not due to pleural disease deserves consideration of aggressive surgical resection with expected 5-year survival of about 20%.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 050472027

Download citation: RISBibTeXText

PMID: 12822610

DOI: 10.1016/s0003-4975(03)00037-7


Related references

Survival rate and prognostic factors of surgically resected clinically synchronous multiple primary non-small cell lung cancer and further differentiation from intrapulmonary metastasis. Journal of Thoracic Disease 9(4): 990-1001, 2017

Prognostic Factors for Surgically Resected N2 Non-small Cell Lung Cancer. Annals of Thoracic and Cardiovascular Surgery 21(3): 217-222, 2015

Prognostic factors for surgically resected stage I-II non-small cell lung cancer. Proceedings of the American Association for Cancer Research Annual Meeting 40: 185, 1999

Prognostic factors for surgically resected non-small cell lung cancer with cavity formation. Journal of Thoracic Disease 10(2): 973-983, 2018

Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer. Annals of Thoracic Surgery 70(4): 1168-1171, 2000

Prognostic factors for patients in postoperative brain metastases from surgically resected non-small cell lung cancer. International Journal of Clinical Oncology 19(1): 50-56, 2014

Poor Prognostic Factors in Surgically Resected Stage I Non-small Cell Lung Cancer: Histopathologic and Immunohistochemical Analysis. Korean Journal of Thoracic and Cardiovascular Surgery 45(2): 101-109, 2012

Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases. European Journal of Cardio-Thoracic Surgery 28(1): 33-38, 2005

Survival and prognostic factors in resected N0 non-small cell lung cancer. Zhongguo Zhongliu Linchuang 30(3): 187-189, 2003

Survival and prognostic factors in resected cN2-pN0 non-small cell lung cancer. Annals of Thoracic and Cardiovascular Surgery 10(1): 9-13, 2004

Survival and prognostic factors in resected satellite-nodule T4 non-small cell lung cancer. Zhonghua Wai Ke Za Zhi 47(2): 120-122, 2009

Recurrence-free survival and prognostic factors in resected pN2 non-small cell lung cancer. European Journal of Cardio-Thoracic Surgery 22(5): 695-700, 2002

Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases. Annals of Thoracic Surgery 63(5): 1441-1450, 1997

Prognostic factors for the survival of surgically treated patients for non-small cell lung cancer. Acta Oncologica 42(4): 338-341, 2003

Prognostic factors including lymphovascular invasion on survival for resected non-small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery 156(2): 785-793, 2018